BML Investment Partners, L.P. 13D/13G Filings for Aerpio Pharmaceuticals, Inc. (ARPO)

BML Investment Partners, L.P. 13D and 13G filings for Aerpio Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-10
3:22 pm
Sale
2021-02-10 13G Aerpio Pharmaceuticals, Inc.
ARPO
BML Investment Partners, L.P. 140,663
4.500%
-12,019decrease
(-7.87%)
Filing